1. Home
  2. CDZI vs FBRX Comparison

CDZI vs FBRX Comparison

Compare CDZI & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$4.02

Market Cap

413.8M

Sector

Utilities

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$17.84

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
FBRX
Founded
1983
N/A
Country
United States
United States
Employees
31
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.8M
487.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CDZI
FBRX
Price
$4.02
$17.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$67.00
AVG Volume (30 Days)
785.6K
225.5K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.30
EPS
N/A
N/A
Revenue
N/A
$36,000.00
Revenue This Year
$12.97
N/A
Revenue Next Year
$102.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$9.12
52 Week High
$6.96
$35.80

Technical Indicators

Market Signals
Indicator
CDZI
FBRX
Relative Strength Index (RSI) 44.70 40.37
Support Level $3.42 $17.33
Resistance Level $5.12 $22.84
Average True Range (ATR) 0.26 1.34
MACD -0.02 0.34
Stochastic Oscillator 26.99 45.44

Price Performance

Historical Comparison
CDZI
FBRX

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: